SCHEMBL7137992

SCHEMBL7137992

COc1ccc(COc2cc(N)c([N+](=O)[O-])cc2I)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.47
MAPT P10636 4/20 0.47
ALDH1A1 P00352 3/20 0.46
LMNA P02545 1/20 0.46
CNR2 P34972 1/20 0.45
APP P05067 2/20 0.44
NPC1 O15118 4/20 0.44
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
HPGD P15428 2/20 0.44
GAA P10253 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 2/20 0.43
TLR4 O00206 1/20 0.43
TLR2 O60603 1/20 0.43
MEN1 O00255 1/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
PTGES O14684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28095853 0.82 MAPT (0.53) CYP19A1MAPTALDH1A1LMNACNR2
SCHEMBL30549816 0.80 ALDH1A1 (0.51) CYP19A1MAPTALDH1A1LMNACNR2
SCHEMBL7141939 0.79 HTT (0.49) MAPTALDH1A1LMNAHTTKMT2A
SCHEMBL7698574 0.79 NPC1 (0.49) CYP19A1MAPTALDH1A1NPC1RAB9A
SCHEMBL25337966 0.79 APP (0.53) CYP19A1MAPTALDH1A1LMNACNR2
SCHEMBL3297532 0.78 CYP19A1 (0.65) CYP19A1MAPTCNR2NPC1RAB9A
SCHEMBL7139766 0.78 ALDH1A1 (0.51) MAPTALDH1A1LMNANPC1RAB9A
SCHEMBL16537734 0.77 MEN1 (0.53) MAPTALDH1A1LMNANPC1RAB9A
SCHEMBL7976948 0.77 NPC1 (0.54) CYP19A1MAPTALDH1A1NPC1RAB9A
SCHEMBL7645892 0.76 KMT2A (0.48) CYP19A1MAPTALDH1A1LMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed